Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brenda E S Gibson

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Experimental Hematology|April 3, 2018
Harnessing the potential of epigenetic therapies for childhood acute myeloid leukemiaAshley A Newcombe, Brenda E S Gibson, Karen Keeshan
British Journal of Haematology|October 31, 2002
The investigation and management of neonatal haemostasis and thrombosisMichael D Williams, Elizabeth A Chalmers, Brenda E S Gibson, et al.
Experimental Hematology|July 3, 2017
Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemiaAlison A Laing, Christine J Harrison, Brenda E S Gibson, et al.
Experimental Hematology|June 9, 2015
Insights into cell ontogeny, age, and acute myeloid leukemiaShahzya S Chaudhury, Jessica K Morison, Brenda E S Gibson, et al.
Haematologica|October 18, 2006
A comparison of the in vitro cytotoxicity of daunorubicin and liposomal daunorubicin in pediatric acute leukemiaBianca F Goemans, Christian M Zwaan, Dirk Reinhardt, et al.
Cancer Genetics and Cytogenetics|May 10, 2006
A diminutive chromosome 21 centromere in acute lymphoblastic leukemiaKathryn A Roberts, Mary Martineau, Zoë J Broadfield, et al.
British Journal of Haematology|September 10, 2011
Results of a randomized trial in children with Acute Myeloid Leukaemia: medical research council AML12 trialBrenda E S Gibson, David K H Webb, Andrew J Howman, et al.
British Journal of Haematology|March 5, 2003
Prognostic factors and outcome for children after second central nervous system relapse of acute lymphoblastic leukaemiaEmma C Morris, Georgina Harrison, Clifford C Bailey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trialAlan K Burnett, Nigel H Russell, Robert K Hills, et al.
Leukemia Research|May 4, 2010
FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657Bianca F Goemans, Christian M Zwaan, Jacqueline Cloos, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Experimental Hematology|April 3, 2018
Harnessing the potential of epigenetic therapies for childhood acute myeloid leukemiaAshley A Newcombe, Brenda E S Gibson, Karen Keeshan
British Journal of Haematology|October 31, 2002
The investigation and management of neonatal haemostasis and thrombosisMichael D Williams, Elizabeth A Chalmers, Brenda E S Gibson, et al.
Experimental Hematology|July 3, 2017
Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemiaAlison A Laing, Christine J Harrison, Brenda E S Gibson, et al.
Experimental Hematology|June 9, 2015
Insights into cell ontogeny, age, and acute myeloid leukemiaShahzya S Chaudhury, Jessica K Morison, Brenda E S Gibson, et al.
Haematologica|October 18, 2006
A comparison of the in vitro cytotoxicity of daunorubicin and liposomal daunorubicin in pediatric acute leukemiaBianca F Goemans, Christian M Zwaan, Dirk Reinhardt, et al.
Cancer Genetics and Cytogenetics|May 10, 2006
A diminutive chromosome 21 centromere in acute lymphoblastic leukemiaKathryn A Roberts, Mary Martineau, Zoë J Broadfield, et al.
British Journal of Haematology|September 10, 2011
Results of a randomized trial in children with Acute Myeloid Leukaemia: medical research council AML12 trialBrenda E S Gibson, David K H Webb, Andrew J Howman, et al.
British Journal of Haematology|March 5, 2003
Prognostic factors and outcome for children after second central nervous system relapse of acute lymphoblastic leukaemiaEmma C Morris, Georgina Harrison, Clifford C Bailey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trialAlan K Burnett, Nigel H Russell, Robert K Hills, et al.
Leukemia Research|May 4, 2010
FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657Bianca F Goemans, Christian M Zwaan, Jacqueline Cloos, et al.
Pageof 2